Development
Cardlytics, Inc.
CDLX
$1.79
$0.116.55%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 3.57% | -1.16% | -0.71% | 4.66% | 11.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.57% | -1.16% | -0.71% | 4.66% | 11.76% |
| Cost of Revenue | -3.86% | -6.01% | -0.90% | 7.81% | 14.24% |
| Gross Profit | 15.86% | 6.75% | -0.40% | -0.19% | 7.89% |
| SG&A Expenses | -25.77% | -19.17% | -12.86% | 0.50% | 18.52% |
| Depreciation & Amortization | -29.52% | -33.95% | -18.61% | -6.62% | 25.69% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.18% | -12.08% | -5.30% | 5.31% | 19.72% |
| Operating Income | 53.16% | 37.66% | 16.17% | -6.92% | -41.91% |
| Income Before Tax | 71.14% | -281.16% | -140.31% | -519.32% | -242.09% |
| Income Tax Expenses | -- | 100.00% | 100.00% | 81.61% | 81.61% |
| Earnings from Continuing Operations | 71.05% | -317.07% | -155.26% | -586.22% | -261.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.05% | -317.07% | -155.26% | -586.22% | -261.89% |
| EBIT | 53.16% | 37.66% | 16.17% | -6.92% | -41.91% |
| EBITDA | 62.18% | 39.31% | 15.10% | -13.29% | -49.26% |
| EPS Basic | 75.15% | -315.66% | -154.70% | -571.90% | -249.06% |
| Normalized Basic EPS | 59.31% | 48.84% | 26.72% | 0.86% | -28.26% |
| EPS Diluted | 75.17% | -306.82% | -150.94% | -550.97% | -250.18% |
| Normalized Diluted EPS | 59.38% | 48.64% | 26.42% | -0.17% | -24.92% |
| Average Basic Shares Outstanding | 9.10% | 4.60% | 0.73% | 0.29% | 3.85% |
| Average Diluted Shares Outstanding | 8.39% | 4.02% | 0.71% | 0.29% | 6.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |